Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Galera Therapeutics

Galera Therapeutics, Inc. (Nasdaq: GRTX), headquartered in Malvern, PA, is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

Galera Therapeutics
Public Companies

Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 22, 2020November 21, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that Mel Sorensen, M.D., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler …

Read More

Galera Therapeutics
Finance

Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates

November 12, 2020November 12, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More
Galera Therapeutics
Finance

Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

November 4, 2020November 4, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on …

Read More

Galera Therapeutics
Products and Services / Research

Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419

October 29, 2020October 29, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) has announced interim data from the full patient population (n=42) in its Phase 1/2 clinical trial of avasopasem manganese (GC4419) in combination …

Read More
Galera Therapeutics
Cancer / Products and Services / Research

Chester County-based Biopharmaceutical Company Shares Positive Data from Pancreatic Cancer Treatment Trial

October 24, 2020October 24, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced the release of the abstract containing interim data from the first 19 patients in its pilot Phase 1/2 clinical trial designed …

Read More

Galera Therapeutics
Products and Services / Research

Galera Therapeutics Announces Dosing of First Patient in the Phase 1/2 GRECO-1 Clinical Trial of GC4711

October 23, 2020October 23, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the first patient has been dosed in the Phase 1/2 GRECO-1 clinical trial of GC4711 in combination with stereotactic body …

Read More
Galera Therapeutics
Cancer / Public Companies

Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer

September 23, 2020September 23, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More

Galera Therapeutics
Products and Services / Research

Chester County-based Biopharmaceutical Company Announces First Patient in Phase 2 Clinical Trial for COVID-19

September 17, 2020September 17, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced the first patient has been dosed in a pilot Phase 2 clinical trial of lead product candidate avasopasem manganese (GC4419) to …

Read More
Galera Therapeutics
Public Companies

Galera Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 15, 2020September 15, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that Mel Sorensen, M.D., President and Chief Executive Officer, will virtually present at the Oppenheimer Fall Healthcare Life Sciences & MedTech …

Read More
Galera Therapeutics
Cancer / Products and Services / Research

Galera Therapeutics Announces Data Presentation at 2020 ASTRO Annual Meeting

September 9, 2020September 9, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that data from its double-blind, placebo-controlled pilot Phase 1b/2a clinical trial of avasopasem manganese (GC4419) in combination with stereotactic body radiation …

Read More

Posts navigation

1 2 3 Next

Most Read

  • Extended Pandemic Emergency Unemployment Benefit Payments Resume this Week
  • Treasury to Work to Ensure Families Get Access to Economic Impact Payments
  • $31 Million in Civil Penalties for Using Internet Bots to Circumvent Limits on Online Ticket Purchases
  • Economic Injury Disaster Loans, Advance Program Reopened to All Eligible Small Businesses, Non-Profits Impacted by COVID-19
  • Another 10 Movies Starring Chester County, PA
  • Biden Administration Expands Nutrition Assistance to Hard-hit Families

Subscribe for Updates

Chester County Events

  • Intro to Practical Defensive Pistol (Indoor)
    • 01/27/2021
      Elverson
  • Machinery Rescue Awareness and Operations
    • 01/30/2021
      West Chester
  • Basic First Aid
    • 01/31/2021
      Malvern
  • Pistol Level 1
    • 01/31/2021
      Malvern
  • Women Willpower Topic: High Value Projects | Host: Lisa Morris
    • 02/09/2021
      West Chester
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • Public Safety Moves to Renovated Space in Lincoln’s International Cultural Center
  • New Members Appointed to Citizens’ Stamp Advisory Committee
  • Pennsylvania Legislative Black Caucus Responds to Equity Report
  • Treasury to Work to Ensure Families Get Access to Economic Impact Payments
Copyright © 2021 MyChesCo.